US Broker Ratings

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: Navigating a 63.78% Potential Upside in the Biotech Sector

BridgeBio Pharma, Inc. (NASDAQ: BBIO) is a prominent player in the biotechnology sector, focusing on innovative solutions for genetic diseases. With a market cap of $13.02 billion, the company is..

Avantor, Inc. (AVTR) Stock Analysis: Navigating Opportunities in the Healthcare Sector

Avantor, Inc. (AVTR), a prominent player in the healthcare sector, offers investors a unique proposition with its extensive range of mission-critical products and services. Headquartered in Radnor, Pennsylvania, Avantor has..

Viatris Inc. (VTRS) Stock Analysis: Exploring a 10.78% Upside with Strategic Collaborations

Viatris Inc. (VTRS) is capturing attention in the healthcare sector, offering a myriad of opportunities for investors keen on the drug manufacturing industry. As a global player, Viatris operates across..

Revvity, Inc. (RVTY) Stock Analysis: A Healthcare Diagnostics Giant with a Cautious Analyst Outlook

Revvity, Inc. (RVTY), a significant player in the healthcare sector, is carving a niche in the diagnostics and research industry. Based in Waltham, Massachusetts, and boasting a market capitalization of..

Ascendis Pharma A/S (ASND) Stock Analysis: Exploring a Potential 31.52% Upside in Biotech Sector

Ascendis Pharma A/S (NASDAQ: ASND), a prominent player in the biopharmaceutical industry, has been making waves with its innovative approach to addressing unmet medical needs. Based in Hellerup, Denmark, this..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: Navigating the Challenges of Growth in the Medical Devices Sector

For investors keen on the healthcare sector, Inspire Medical Systems, Inc. (NASDAQ: INSP) offers a compelling case study in the medical devices industry. Headquartered in Golden Valley, Minnesota, this innovative..

Stryker Corporation (SYK) Stock Analysis: Healthcare Giant Poised for 36% Upside

Stryker Corporation (NYSE: SYK), a titan in the medical devices industry, is presenting an intriguing opportunity for investors. With a market capitalization of $105.53 billion, Stryker operates at the forefront..

iRhythm Holdings, Inc. (IRTC) Investor Outlook: Potential 61% Upside Amid Innovative Cardiac Solutions

iRhythm Holdings, Inc. (NASDAQ: IRTC), a standout in the healthcare sector specializing in medical devices, is capturing the attention of investors with a notable potential upside of 61.11%. The company,..

Solventum Corporation (SOLV) Investor Outlook: Evaluating a 5.72% Upside with Robust ROE Metrics

Solventum Corporation (SOLV), a significant player in the healthcare sector, is drawing attention from investors with its potential upside of 5.72% and an impressive Return on Equity (ROE) of 33.96%...

Doximity, Inc. (DOCS) Stock Analysis: Exploring the 14.69% Potential Upside for Healthcare Investors

Doximity, Inc. (NYSE: DOCS), a prominent player in the health information services industry, presents a unique investment opportunity with a projected potential upside of 14.69%. With a current market capitalization..

Novo Nordisk A/S (NVO) Stock Analysis: Uncovering Growth Potential Amidst Healthcare Innovation

Novo Nordisk A/S (NYSE: NVO), a prominent player in the healthcare sector, is a beacon of innovation in the drug manufacturing industry. Headquartered in Bagsvaerd, Denmark, the company is renowned..

Corcept Therapeutics (CORT) Stock Analysis: A Promising Biotech with 27.84% Upside Potential

Corcept Therapeutics Incorporated (NASDAQ: CORT) stands out as a compelling player in the biotechnology sector. With a robust market capitalization of $11.92 billion, the company is making significant strides in..

The Cigna Group (CI) Investor Outlook: Analysts Signal 23% Upside Potential

The Cigna Group (NYSE: CI), a formidable player in the healthcare plans industry, stands as a compelling investment opportunity with a market capitalization of $72.74 billion. Operating primarily in the..

Insmed Incorporated (INSM) Stock Report: A Biotech Powerhouse with 66% Potential Upside

For investors with a keen interest in biotechnology, Insmed Incorporated (NASDAQ: INSM) presents a compelling opportunity. With a market cap of $26.21 billion, this U.S.-based healthcare innovator focuses on developing..

Jazz Pharmaceuticals plc (JAZZ) Stock Analysis: A Biotech Powerhouse with 20% Upside Potential

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a prominent player in the healthcare sector, specifically within the biotechnology industry, has captured the attention of investors with its impressive 20.71% potential upside. Based..

TG Therapeutics, Inc. (TGTX) Stock Analysis: Exploring a 22.59% Upside Potential in the Biotech Sector

TG Therapeutics, Inc. (NASDAQ: TGTX) is capturing the attention of investors with its promising 22.59% potential upside, according to the latest analyst ratings. As a key player in the healthcare..

Molina Healthcare Inc (MOH) Stock Analysis: Navigating Healthcare Under the Spotlight with a 4.15% Upside

Molina Healthcare Inc (NYSE: MOH), a prominent player in the healthcare plans industry, is drawing investors’ attention with its unique positioning in the managed healthcare sector. With its primary focus..

Qiagen N.V. (QGEN) Stock Report: A Healthcare Giant with a Potential Upside of 6.78%

Qiagen N.V. (QGEN), a prominent player in the healthcare sector, continues to be a focal point for investors in the diagnostics and research industry. Headquartered in Venlo, Netherlands, Qiagen specializes..

AstraZeneca PLC (AZN) Stock Analysis: Is a 27.75% Upside on the Horizon?

AstraZeneca PLC (NASDAQ: AZN), a leading biopharmaceutical company headquartered in Cambridge, UK, continues to capture investor attention with its robust pipeline of prescription medicines and strategic partnerships. With a market..

Bruker Corporation (BRKR) Stock Analysis: Assessing Growth Potential Amid a Rapidly Evolving Medical Devices Sector

Bruker Corporation (NASDAQ: BRKR) stands as a prominent player in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $9.35 billion, this Massachusetts-based company has..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds